A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring.

Source:http://linkedlifedata.com/resource/pubmed/id/7842406

Cancer 1995 Feb 15 75 4 1038-44

Download in:

View as

Triples

General Info

PMID
7842406